Linked Life Data

21536175

Source:http://linkedlifedata.com/resource/pubmed/id/21536175

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2011-5-3
pubmed:abstractText
Pulmonary Hypertension (PH) is a haemodynamical disorder; its definite diagnosis requires an increase of mean pulmonary arterial pressure measured by right heart catheterization (RHC). This invasive test allows to distinguish between precapillary and postcapillary PH and also to measure the vasoreactivity before starting specific therapy. Pulmonary arterial hypertension (PAH) – group 1 of PH – comprises heterogeneous condition which presents identical histological findings. In the recent guidelines, task force suggests that transthoracic echocardiography (TTE) should be considered as a tool for assessment of the likely presence or absence of PH with different level of evidence. On the basis of this assessment patients can be referred for a confirmatory RHC. In addition to its role in diagnosis, TTE can be used to screen for high-risk patients population, to asses prognosis and to monitor disease stability and response to treatment. Even if TTE doesn't prove yet its major role in management of PAH patients, it is essential to include this safe and noninvasive exam in a goal-oriented approach to therapy.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0755-4982
pubmed:author
pubmed:issnType
Print
pubmed:volume
40 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1S14-20
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
[Echocardiography: interest and border for screening and monitoring of pulmonary arterial hypertension].
pubmed:affiliation
Hôpital de la Timone, Service de Cardiologie, Marseille, France.
pubmed:publicationType
Journal Article, English Abstract, Review